Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,495,232
+$908,288 QoQ
Shares Held
58,135
+90.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#108
of 290 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. DNLI ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in DNLI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,495,232 | 58,135 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $586,944 | 30,570 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $245,939 | 16,938 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $236,123 | 16,878 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $525,351 | 38,643 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,253,885 | 110,593 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,419,658 | 117,393 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,710,772 | 116,743 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,650,402 | 80,429 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,743,495 | 81,244 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,173,471 | 153,828 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,668,742 | 124,322 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $211,506 | 9,180 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $255,462 | 9,186 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $254,388 | 8,289 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $242,354 | 8,235 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $667,622 | 20,753 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,624,724 | 215,801 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,457,457 | 187,462 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,257,897 | 220,014 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,731,601 | 187,944 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,514,862 | 89,719 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,211,233 | 33,805 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||